Example: Heart Attack

Clinical Trials on Metrorrhagia

Total 297 results

NCT00475553

Completed

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

Conditions: Breakthrough Bleeding; Breakthrough Spotting
NCT00307801

Completed

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Conditions: Metrorrhagia
NCT00293059

Completed

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Conditions: Metrorrhagia
NCT02326922

Completed

The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding

Conditions: Dysfunctional Uterine Bleeding
NCT00344383

Completed

An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen

Conditions: Metrorrhagia
NCT04528108

Not yet recruiting

Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome

Conditions: Dysfunctional Uterine Bleeding
NCT00563576

Completed

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

Conditions: Metrorrhagia
NCT04396483

Active, not recruiting

Dysfunctional Uterine Bleeding After Tubal Sterilization

Conditions: Contraception; Dysfunctional Uterine Bleeding
NCT03121560

Completed

Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation

Conditions: Metrorrhagia
NCT00320580

Completed

An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

Conditions: Metrorrhagia
NCT04290013

Not yet recruiting

Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .

Conditions: Dysfunctional Uterine Bleeding
NCT01557023

Withdrawn

Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol

Conditions: Metrorrhagia
NCT00394771

Completed

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Conditions: Breakthrough Bleeding
NCT02824224

Completed

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Conditions: Menorrhagia; Metrorrhagia; Medicated Intrauterine Devices
NCT02300805

Completed

Accuracy of Endometrial Volume Measured by VOCAL Versus Office Hysteroscopy for Diagnosis of Endometrial Polyps

Conditions: Premenopausal; Metrorrhagia
NCT01295294

Completed

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Conditions: Uterine Hemorrhage
NCT01173965

Completed

Endometrial Ablation With Non-hysteroscopic Methods

Conditions: Dysfunctional Uterine Bleeding
NCT00114088

Completed

Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)

Conditions: Menorrhagia; Uterine Bleeding
NCT04047875

Not yet recruiting

Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant

Conditions: Breakthrough Bleeding
NCT02248194

Completed

Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding

Conditions: Dysfunction Uterine Bleeding
NCT00120913

Completed

Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?

Conditions: Breakthrough Bleeding
NCT00549159

Unknown status

CavatermTM vs TCRE in Women With DUB

Conditions: Dysfunctional Uterine Bleeding
NCT04579965

Not yet recruiting

Misotac vs Combined Oral Contraceptive Pill in the Treatment of Symptomatic Isthmocele

Conditions: Dysfunctional Uterine Bleeding
NCT00064766

Unknown status

Norplant and Irregular Bleeding/Spotting

Conditions: Endometrial Bleeding; Periodontal Disease
NCT01935544

Completed

Effectiveness of Two Techniques in Injection Site Spotting for Botulinum Toxin Injections: Echography or Electro Stimulation.

Conditions: Stroke